ZenoWell vagus nerve stimulation for women’s wellness

Throughout life, women are constantly dealing with hormonal changes. Monthly menstrual cycles, postpartum, and the long transition around menopause all leave a mark on both body and mind. Poor sleep, high stress, anxiety, mood swings, fatigue, and of course, the all‑too‑familiar menstrual pain—these are not just “in your head”.

These experiences are not only about hormones. Increasingly, research shows they are closely linked with the autonomic nervous system—especially the balance between the sympathetic nervous system (our “fight‑or‑flight” mode) and the vagus‑driven parasympathetic system (our “rest‑and‑restore” mode). You can think of them as the body’s “gas pedal” and “brake”. One key concept here is vagal tone: the healthier it is, the more easily we can switch between stress and relaxation. Better vagal tone is linked to better sleep, lower stress, less pain, and more stable mood.

Against this background, a gentle, non‑invasive technology has entered the field of women’s health: transcutaneous auricular vagus nerve stimulation (taVNS). In simple terms, it stimulates the vagus nerve through the skin of the ear. In this article, we’ll explain in clear language how hormonal changes affect the nervous system, what role the vagus nerve plays, and how taVNS may support women through different hormonal stages.

Why hormonal shifts affect sleep, mood, stress, and pain

During the menstrual cycle, estrogen and progesterone rise and fall across different phases. These hormones do far more than act on the uterus and ovaries—they also affect the brain, blood vessels, and neural circuits that control heart rate, blood pressure, mood, and pain perception.

A 2025 review in NeuroSci looked specifically at how the menstrual cycle influences the autonomic nervous system. The authors examined indicators like heart rate variability (HRV, a marker of vagal activity), baroreflex sensitivity (how well the body stabilizes blood pressure), and sympathetic nerve activity. The patterns they found match what many women feel in real life: certain phases are associated with more fatigue, irritability, poor sleep, and increased sensitivity to pain.

In simple terms:

Around menstruation, when both estrogen and progesterone are low, the body tends to drift into a “stress‑like” mode. The sympathetic system becomes more active, the vagus nerve is relatively less engaged, heart rate may be slightly higher, and the body feels more tense. Many women experience lower mood, more anxiety, and greater sensitivity to pain in this phase. This is why you may feel more “fragile” or on edge around your period—it’s not you overreacting; your nervous system is literally in a different physiological state.

Around ovulation, when estrogen rises, some studies suggest vagal activity improves and many women feel more emotionally stable, more energetic, and clearer in their thinking. In the luteal (pre‑menstrual) phase, progesterone rises again and is linked in some research to increased sympathetic drive and reduced vagal regulation. For some women, this shift contributes to PMS or PMDD: irritability, depressed mood, anxiety, insomnia, or feeling easily overwhelmed, often have an autonomic component behind them.

Menopause tells a similar story, but stretched over years instead of days. A 2025 review in Autonomic Neuroscience highlighted that cardiovascular risk in women rises sharply around menopause, and a major reason is the loss of estrogen’s protective influence on the autonomic and vascular systems. With age, sympathetic activity naturally increases, but in women around midlife this rise can be steeper. When estrogen levels fall:

  • Sympathetic “gas pedal” activity tends to increase
  • Vagal “brake” on heart rate and blood pressure becomes weaker
  • Blood vessels become stiffer and less responsive

Common menopausal symptoms like hot flashes, night sweats, poor sleep, palpitations, and mood swings are all closely tied to these autonomic shifts.

You can think of it this way: whether it’s the monthly menstrual cycle or the menopausal transition, hormones are constantly turning the dials on the autonomic nervous system. When the sympathetic system stays “on” too much and the vagus nerve is underactive, women are more likely to feel anxious, in pain, exhausted, sleepless, and physically unsteady.


The vagus nerve: the master regulator of body–mind balance

The vagus nerve is the main parasympathetic nerve in the body. It runs from the brainstem down to the heart, lungs, and digestive organs. It’s like a high‑speed communication highway: it sends information from the organs to the brain and carries “rest, heal, and calm down” messages from the brain back to the body.

For women, the vagus nerve is deeply involved in several key areas:

First, stress and cortisol regulation. The better your vagal tone, the more resilient you tend to be under stress. You can recover more quickly after something stressful happens. When vagal tone is low, it’s easy to feel stuck in a “constant fight‑or‑flight mode”: always tense, easily overwhelmed, and unable to fully relax.

Second, pain and inflammation. The vagus nerve helps control inflammatory responses through what’s called the cholinergic anti‑inflammatory pathway. Inflammation, pain, and mood are often tightly connected. Many people with chronic pain also struggle with anxiety and depression. Research suggests that supporting vagus nerve activity can help improve pain and emotional distress in certain conditions.

Third, heart rate and blood pressure. The vagus nerve is the body’s natural brake: it slows the heart rate and helps keep blood pressure variability within a healthy range. This is especially important around menopause, when sympathetic activity tends to rise; without enough vagal braking, palpitations and high blood pressure can become more common.

Finally, mood and cognition. Vagal signals influence brain areas involved in emotional regulation, attention, and decision‑making. Better vagal function is often associated with stronger self‑regulation and emotional stability.

So when women experience mood swings, worsening pain, poor sleep, or heightened stress around “that time of the month,” postpartum, or during peri‑ and post‑menopause, what’s happening under the surface is often a shift toward sympathetic dominance and reduced vagal regulation—the autonomic system is out of balance.


What is taVNS, and how might it help?

Transcutaneous auricular vagus nerve stimulation (taVNS) sounds technical, but the principle is quite straightforward. Certain parts of the outer ear—such as the cymba concha and cavum concha—are innervated by a branch of the vagus nerve. By placing small electrodes on these spots and delivering very mild, safe electrical pulses, we can gently activate the vagus nerve through the skin.

Unlike traditional implanted VNS, taVNS:

  • Requires no surgery
  • Is applied externally on the ear
  • Can be used at home or in daily life
  • Is non‑invasive and designed to be comfortable

You can think of it as a “gentle nerve therapy through the ear” that you can integrate into your routine.

In women’s health, the clearest and most direct evidence so far comes from studies on primary dysmenorrhea (menstrual pain without structural disease like fibroids or endometriosis).

A randomized controlled trial published in Neuromodulation in 2025 recruited 34 women with primary dysmenorrhea. They were randomly assigned to either real taVNS or sham stimulation (which looked the same but did not actually stimulate the vagus nerve). The treatment protocol was simple: starting 5 days before the expected second menstrual period, the women used taVNS once a day for 5 consecutive days. Electrodes were placed on the tragus and nearby ear areas, with stimulation at 10 Hz for 5 minutes at a comfortable intensity.

The results were striking. Compared with the sham group, women using taVNS had significantly less pain during their next period. Their pain ratings went down, and their tolerance to pressure pain improved. Importantly, it wasn’t just the pain that changed: their menstrual symptom questionnaires showed fewer daily life disruptions, their anxiety scores dropped, and they even did better on a 6‑minute walking test, reflecting better physical functioning and overall state. This suggests that taVNS is not simply “numbing the pain,” but helping the nervous system regulate pain and emotional responses more effectively.

An earlier pilot study in Brain Stimulation also found that 10 days of taVNS applied to the left ear reduced both the duration and intensity of menstrual pain, along with overall menstrual symptom burden.

Taken together, these studies point in the same direction: gentle vagus nerve stimulation through the ear can reduce menstrual pain, lower pain sensitivity, and ease the anxiety and emotional toll that often come with painful periods.

Although the uploaded articles focus mainly on dysmenorrhea and the autonomic aspects of menopause, other research has explored taVNS in migraine, depression, certain abdominal pain conditions, and sleep problems, with encouraging results. For women in midlife and beyond, there is a strong theoretical basis for using taVNS to support:

  • Distress related to hot flashes and night sweats
  • Menopause‑related anxiety, stress, and autonomic “over‑activation”
  • Heart rate and blood pressure regulation as an adjunct to medical care

In other words, taVNS is not a magic cure for one specific disease, but a way to support vagus nerve function and autonomic balance—helping the body maintain inner stability across changing hormonal landscapes.


Our vision: a “pocket‑sized comfort tool” for hormonal transitions

We hope taVNS can become more than just a neuromodulation device. Our vision is for it to be a supportive tool women can lean on across different life stages.

For many, “those days” mean pain, low mood, reduced productivity, and a tendency to withdraw from social life. The premenstrual days can bring irritability and anxiety. Perimenopause can feel like a long rollercoaster of emotional and physical upheaval. Our wish is that you don’t have to simply endure all of this without support.

Imagine using taVNS as a small ritual of self‑care: in the days before your period, you take a few minutes for a session to gently prepare your nervous system. During painful days, you combine it with a hot water bottle, rest, and some deep breathing to help your body step back from constant sympathetic overdrive. On nights when premenstrual mood swings or anxiety keep you awake, a short taVNS session before bed, perhaps paired with meditation or calming music, becomes your way of pressing “pause”.

For women in menopause, taVNS could be a “pocket‑sized comfort tool” when hot flashes, night sweats, palpitations, or irritability flare up. Instead of feeling completely at the mercy of these symptoms, you have something practical to help you gradually regain a sense of control.

We also believe that beauty is not just about skin or appearance; it’s an inner sense of stability, safety, and vitality. When stress is lower, sleep is better, and pain no longer dominates your life, your entire presence changes. You don’t just look better—you genuinely feel better.

Our intention in developing taVNS technology is simple:

  • To be there when you need support—not only in hospitals, but in your everyday life.
  • To fit into the small pockets of time in your busy schedule and give you a moment of repair.
  • To quietly accompany you through each hormonal wave, helping you move more smoothly through every cycle and every big transition.

Of course, research on taVNS in different aspects of women’s health—especially around menopause—is still evolving. Safety and proper use are extremely important. taVNS does not replace medical diagnosis or treatment. Women with heart disease, implanted pacemakers, epilepsy, pregnancy, or other special conditions should consult a healthcare professional before use. But as scientific evidence grows, we are already seeing that gently supporting the vagus nerve can genuinely help many women navigate those “hormone‑heavy” times with more ease.

Our vision is straightforward:
As your body and life change, we want you to be able to meet each phase more calmly, live more comfortably, and truly—feel better, look better, and glow always.

Reference: 

Kızkın, Zeynep Yıldız, Rıdvan Yıldız, and Ali Veysel Özden. "Effects of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals with Primary Dysmenorrhea: A Randomized Controlled Trial." Neuromodulation: Technology at the Neural Interface (2025).

Lee, E. J., and M. L. Keller-Ross. "Menopause and its effects on autonomic regulation of blood pressure: Insights and perspectives." Autonomic Neuroscience (2025): 103295.

Roy, Sankanika, Elettra Agordati, and Thomas DW Wilcockson. "Autonomic nervous system, cognition, and emotional valence during different phases of the menstrual cycle—a narrative review." NeuroSci 6.3 (2025): 78.

Stokes, William H., et al. "Vasomotor symptoms of menopause, sympathetic activity, and blood pressure in postmenopausal females." American Journal of Physiology-Heart and Circulatory Physiology (2025).

Wang, Chenxi, et al. "Transcutaneous auricular vagus nerve stimulation for the treatment of primary dysmenorrhea: A pilot study." Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation 16.3 (2023): 695-697.

 

Related Posts

研究前沿|隨機對照研究證實,經皮耳迷走神經刺激能有效減輕肩關節鏡手術後的反彈性疼痛

簡介 神經阻滯消退時的疼痛 肩關節鏡手術後,疼痛起初可能控制良好,但隨著神經阻滯消退,疼痛可能突然加劇。這種由輕微疼痛轉為劇烈疼痛的過程稱為反彈痛,可能干擾休息與術後恢復。在阻滯作用逐漸減弱時維持穩定鎮痛,仍是圍手術期疼痛管理的重要挑戰。 2026年9月15日,Jun Zhang及其同事在《Regional Anesthesia & Pain Medicine》發表一項隨機、假刺激對照試驗,研究經皮耳部迷走神經刺激(taVNS)是否能降低肩關節鏡手術後反彈痛的發生率。 研究納入120名患者,將taVNS與假刺激,和常規麻醉及鎮痛方案進行比較。手術後24小時內,taVNS組較少出現反彈痛,部分恢復及睡眠指標也有所改善。然而,平均疼痛分數的下降幅度很小,兩組鎮痛藥使用量的差異未達統計學顯著。 背景 反彈痛管理的缺口 單次肌間溝臂叢神經阻滯(ISB)是肩部手術常用的區域鎮痛技術。局部麻醉劑作用於神經周圍,可提供約12至24小時的鎮痛,但藥效消退時,手術部位的疼痛可能迅速出現。因此,評估鎮痛策略時應單獨關注反彈痛:單日平均疼痛分數可能無法充分反映這種急劇而短暫的變化。 連續神經周圍導管及輔助藥物有助於處理這個問題,但也會增加操作、管理或藥物相關負擔。taVNS透過貼於耳部皮膚的電極刺激迷走神經耳支,為研究輔助鎮痛提供另一途徑。其給予方式不同於植入式迷走神經刺激、經皮頸部刺激及針刺式耳部神經調節。 過去研究曾探討耳部神經刺激對術後疼痛的影響,但針對單次ISB後反彈痛的證據仍有限。本試驗事先將反彈痛指定為主要終點,並在既有多模式鎮痛基礎上測試taVNS的附加效果。 方法 隨機比較與刺激方案 這項單中心試驗在中國浙江省德清縣人民醫院進行。在接受篩查的142人中,120名符合條件且安排接受肩關節鏡手術的患者按1:1隨機分組,每組60人。所有患者均完成追蹤,並納入意向治療分析。患者、結果評估者及資料分析人員均保持盲法;負責施加刺激的人員知道分組。 兩組均接受全身麻醉、一次性超聲引導ISB,以及標準化靜脈布洛芬和患者自控舒芬太尼鎮痛。ISB使用15毫升0.5%羅哌卡因。taVNS施加於左側耳甲艇,頻率30 Hz、脈衝寬度250 μs,刺激30秒、休息30秒交替進行。強度逐步提高,直到患者感到明顯麻刺感,再降低至患者確認無感覺的程度。首次治療在術前等候區開始,拔管後轉入麻醉後照護單位前持續進行。術後第1及第2天早上各進行一次2小時治療。假刺激組接受相同的電極放置及感覺閾值測試,但治療期間裝置輸出設定為零。 主要結果是手術後24小時內反彈痛的發生率。研究人員使用0至10分數字評分量表(NRS),將反彈痛定義為阻滯消退後疼痛由≤3升至≥7,且至少上升4分。阻滯消退是根據疼痛變化推定,並未透過連續感覺檢查確認。次要結果包括術後6、12、24及48小時的疼痛與舒芬太尼累積用量、恢復品質、睡眠品質及不良事件。主要結果採用卡方檢驗分析,重複測量的次要結果採用混合效應模型。恢復及睡眠分數的時間點比較進行Bonferroni校正。樣本量按主要終點估算;次要結果分析屬探索性質。 結果 主要終點與效果量...
發表者 Dr. XIAOJane
Oct 13 2026

2026 世界心理健康日:主題與有意義的行動

2026 世界心理健康日為 10 月 10 日星期六。世界衛生組織(WHO)與 World Federation for Mental Health(WFMH)公布的官方主題是「Lived experiences heard: real voices, real change」[1], [2]。今年的倡議重點,是傾聽具有心理健康相關親身經驗的人,並讓他們真正參與影響自身生活的決策、服務與政策。 個人、職場與社區都可以透過實際支持、自願參與的對話、心理健康倡議活動,以及在活動日之後持續進行的行動來參與。真正有意義的參與不需要大型活動,也不一定需要預算。2026 世界心理健康日的核心,是把「提高關注」與「傾聽」轉化為真正的參與及長期支持。 2026 世界心理健康日的主題是什麼? 2026 世界心理健康日的官方主題是「Lived...
發表者 Dr. XIAOJane
Oct 10 2026

Research Frontiers|33 萬人睡眠數據顯示:健康睡眠模式與較低失智症風險相關

中年睡眠與大腦健康 中年時期的睡眠習慣,和十多年後的失智症風險有什麼關係?一項超過 33 萬人的研究,同時分析多項睡眠特徵,包括每天的睡眠時間、頻繁失眠與白天嗜睡,評估這些特徵和日後失智症之間的關聯。 這項研究由 Tao Wei、Jie Chang 與同事進行,並於 2025 年 9 月 30 日發表在 Alzheimer's Research & Therapy。研究使用 UK Biobank 資料,參與者在納入研究時年齡為 40 至...
發表者 Dr. XIAOJane
Oct 10 2026

系統性綜述|迷走神經刺激用於風濕性疾病的臨床證據與機制進展

 疼痛、疲勞與反覆發炎,是許多風濕性疾病患者長期面對的問題。藥物治療已取得顯著進展,但部分患者仍無法獲得充分的疾病控制。因此,研究人員開始探索一種互補策略:透過調節神經系統,影響與發炎相關的免疫活動。 2026 年,Anna Wysokińska 等人在 Rheumatology International 發表一篇綜述,探討迷走神經刺激(VNS)用於風濕性疾病的作用機制與臨床證據。作者納入了 15 項原始人體研究,涵蓋類風濕性關節炎、系統性紅斑狼瘡、乾燥症候群、脊椎關節炎、骨關節炎、纖維肌痛以及其他疾病。 VNS 在發炎、疼痛、疲勞與疾病活動度方面顯示出潛在益處。不過,不同疾病與研究之間的結果並不一致,目前在刺激方式、治療參數與追蹤時間上也尚未形成統一標準。 圖 1. 綜述論文首頁節錄。文章探討自律神經調節、發炎與臨床結果之間的關聯,並被歸類為綜述文章。 背景:神經免疫通路 自律神經系統(ANS)功能異常在風濕性疾病中很常見,通常表現為交感神經活動增加,同時由迷走神經介導的副交感神經調節減弱。該綜述指出,這種失衡會伴隨慢性發炎,但目前證據仍無法判定,自律神經功能異常究竟是疾病的結果,還是也參與疾病的發生與持續。 約 80% 的迷走神經纖維屬於傳入纖維,20% 屬於傳出纖維。傳入訊號進入腦幹後,孤束核等結構可以影響下視丘—腦下垂體—腎上腺軸,該系統參與壓力反應與皮質醇調節。傳出通路則與膽鹼能抗發炎通路相關。當乙醯膽鹼與巨噬細胞上的 α7 菸鹼型乙醯膽鹼受體結合時,可抑制腫瘤壞死因子 α...
發表者 Dr. XIAOJane
Sep 29 2026

睡眠呼吸中止症與失智症:為什麼研究人員正在研究 taVNS?

打鼾、反覆喘氣、突然驚醒、早晨沉重疲憊以及白天精疲力盡都很常見。很多人會把這些情況當成睡得很沉或只是普通疲勞。但如果大聲打鼾同時伴隨呼吸暫停,就可能提示阻塞性睡眠呼吸中止症。每一次呼吸道阻塞都可能中斷睡眠,並讓大腦再次經歷氧氣下降與恢復的循環。 人一生中接近三分之一的時間都在睡眠中度過。睡眠期間,大腦會鞏固記憶、調節神經活動、清除代謝廢物,並為第二天的注意力與學習系統做準備。反覆的呼吸中斷可能一晚又一晚地干擾這些過程。 taVNS 之所以進入這個議題,是出於不同的原因。它不能重新打開被阻塞的呼吸道。研究人員對它感興趣,是因為迷走神經通路與參與喚醒、睡眠、注意力、記憶與自律神經調節的腦部系統相連。因此真正值得研究的問題,不是 taVNS 是否「治療睡眠呼吸中止症」,而是影響這些相互重疊的系統,未來是否可能在睡眠與認知健康研究中扮演輔助角色。                 研究如何看待睡眠呼吸中止症與失智症風險? 阻塞性睡眠呼吸中止症會在睡眠期間反覆使上呼吸道變窄或阻塞。每一次事件都可能降低氧氣、引發短暫覺醒,並迫使身體重新恢復呼吸。中度或重度 OSA 患者每小時可能經歷數十次這種情況,使大腦反覆暴露在缺氧與睡眠片段化的壓力之下。 目前最有力的近期總結,是 2024 年更新的一項統合分析,納入 15 項研究、共 5,207,312 人。與沒有睡眠呼吸中止症的人相比,患有睡眠呼吸中止症者的全因失智症發生率高出...
發表者 Dr. XIAOJane
Sep 24 2026

降低阿茲海默症風險,可以從睡前開始

阿茲海默症可能在記憶問題變得明顯之前很久,就已開始改變大腦,因此更早關注日常健康尤其重要。在世界阿茲海默症月期間,我們把睡眠視為一項每天都能觀察、並可隨時間逐步強化的習慣。我們探討睡眠可能如何影響與阿茲海默症相關的生理過程,以及夜間恢復對 APOE4 攜帶者可能代表什麼;這一族群發生晚發型阿茲海默症的風險較高。為了探索這個問題,ZenoWell 與 phoenix community 追蹤了 31 名 APOE4 攜帶者,他們在睡前使用 taVNS,並觀察到睡眠分數、HRV、能量、整體感受與主觀睡眠品質出現令人鼓舞的變化。 為什麼世界阿茲海默症月值得關注 每年九月,世界阿茲海默症月都會把全球注意力帶到阿茲海默症,以及它對患者、家庭、照護者與醫療系統日益增加的影響。隨著人口老化,愈來愈多人與失智症共存,因此更早的認知與長期大腦健康也變得更加重要。 [1] 阿茲海默症不同於偶爾忘記一個名字、把東西放錯地方,或走進房間後一時忘記自己原本要做什麼。它的影響是漸進性的。隨著時間推移,一個人可能逐步失去對熟悉記憶、人際關係、日常習慣,以及構成個人身分的重要生命經歷的連結。 [2] 這也帶出一個更迫切的問題:在這些變化變得明顯之前,我們可以做些什麼? 沒有任何單一日常習慣可以保證預防阿茲海默症。不過,研究顯示,有些健康因素可能值得更早關注。其中一個最熟悉、可量化、卻也常被忽略的因素,就是我們每天晚上都會做的事:睡眠。 為什麼我們關注 APOE4、睡眠與睡前時段 如果要更早觀察大腦健康,睡眠是最實際的切入點之一。它每天晚上都會發生,而且在明顯認知問題出現之前,睡眠變化往往已可被注意到;同時,睡眠也支持許多有助於大腦長期維持自身狀態的生理過程。 [3-6] 睡眠期間,尤其是在較深的非快速動眼睡眠階段,大腦仍會持續整理記憶、調節神經活動並移除代謝廢物。參與這項夜間維護工作的系統之一,是膠淋巴系統;這是一條液體運輸通路,可協助將代謝廢物穿過並排出腦組織。...
發表者 Dr. XIAOJane
Sep 23 2026

真正的好睡眠是什麼樣子?

2026 年 9 月,台灣藝人兼籃球管理人士 Chen Chien-chou 因心肌梗塞住院時,關於他康復情況的報導中有一個細節格外引人注意。他表示,過去六年多來,自己經常每晚只睡三到四個小時。這段個人陳述無法證明心肌梗塞的原因,但它確實描述了一種很常見的習慣:把工作與家庭責任之外剩下的時間才留給睡眠。 大多數人都知道什麼時候一晚睡得明顯太少,但「好的睡眠」其實更難界定。八小時就足夠嗎?半夜醒來是否代表睡眠出了問題?而我們又應該在多大程度上,根據隔天的感受來判斷睡眠品質? 健康睡眠包括足夠的實際睡眠時間、相對穩定的作息時間、良好的睡眠連續性,以及白天能夠維持良好功能。這些面向都能提供單純計算每晚睡了幾個小時所無法呈現的資訊。 足夠的睡眠時數是起點 對大多數成年人而言,每晚睡 7 到 9 小時是一個實用的整體參考目標。每個人的需求不同,生病或睡眠受到干擾時,也可能需要更多休息。這裡指的是實際睡著的時間;在床上躺八個小時,其中可能有相當一段時間其實是清醒的。 一整晚中,大腦會在非快速動眼睡眠(non-REM)與快速動眼睡眠(REM)之間循環。非 REM 睡眠包含較淺的睡眠階段,以及較深的慢波睡眠。這些階段會在夜間反覆出現。 深度睡眠只是這個不斷變化模式中的一部分,因此整晚都處於最深睡眠並不是目標。睡眠週期之間也可能出現短暫醒來。單純記得自己曾醒過一次,並不代表那一晚一定睡得不好。 好的睡眠有自己的節律 睡眠時間點描述的是你在什麼時候睡,而規律性則描述這些時間每天變動多少。晚睡、早起,再搭配長時間補眠的作息,即使平均睡眠時數看起來相近,也可能與穩定的作息非常不同。American Heart Association 在睡眠健康框架中,除了睡眠時長與白天功能之外,也將睡眠時間與規律性納入考量。...
發表者 Dr. XIAOJane
Sep 22 2026

為什麼 taVNS 通常使用左耳?從心臟安全疑慮到刺激側別的研究證據

在耳朵上放置電極時,多數人會預期它放在左耳。這種習慣有其歷史背景,但很容易把歷史慣例誤認為科學證據。2024 年一項範疇性回顧發現,在 84 項有報告刺激側別的臨床研究中,約 62% 使用左耳、11% 使用右耳,另有 27% 使用雙耳。 為什麼左側如此常見?右耳刺激會不會對心臟有風險?左耳是否真的已被證明效果更好?最簡單的解釋是,這是一項基於謹慎而形成的慣例。當早期某套刺激協議看起來安全且可行後,後續研究往往沿用同一側,因此較少有動機去測試其他選擇。 2026 年發表的綜述也指向相同方向。這些文獻將左耳、右耳與雙耳刺激都視為可接受的方法,但並不把左耳研究數量較多解讀為療效排名。在認知與中風復健相關綜述中,左耳刺激協議仍占主流,但最佳刺激側別與刺激參數仍未有定論。 左耳慣例最初源自頸部刺激 植入式迷走神經刺激最早出現,其電極通常放置在左側頸部迷走神經周圍。原因與心臟生理有關。右側迷走神經對負責設定心跳節律的竇房結影響較強,而左側則對房室傳導的影響較大。為了降低直接影響心率的可能性,左側因此成為較保守的選擇。 但這種左右分工並非絕對。經典動物研究顯示,無論刺激哪一側,只要刺激夠強,都可能減慢心跳或改變傳導。選擇左側只是較謹慎的起點,並不代表另一側永遠不會產生重要影響。 當研究人員從頸部刺激轉向耳部刺激時,原有的左側慣例也一併延續下來。此時電極接觸的是不同的神經纖維,但既有協議已相當熟悉。 耳部刺激走的是不同神經路徑 頸部刺激可能同時影響迷走神經中的傳入感覺纖維與傳出自律神經纖維。taVNS 主要針對迷走神經耳支,也就是分布於部分外耳區域的感覺神經通路。訊號會傳至腦幹,再進一步影響更廣泛、可能調節身體功能的神經網絡。 在 2015 年一項人體影像研究中,Frangos 及其同事對 12...
發表者 Dr. XIAOJane
Sep 21 2026